Texas Sues Epic Systems, Alleging Monopolistic Control of Patient Data
The lawsuit filed Wednesday accuses the electronic health record giant of stifling competition and limiting parental access to children’s medical information.
Texas Attorney General Ken Paxton has launched a legal challenge against Epic Systems, alleging the company illegally maintains a monopolistic grip on the nation’s electronic health records (EHR) market. The suit, filed in a Texas state court, claims Epic’s dominance prevents hospitals from switching vendors and hinders competition, ultimately impacting patient care and data accessibility. A key component of the complaint centers on restrictions placed on parental access to their children’s health information through the company’s MyChart patient portal.
Epic’s Market Share and Allegations of Anti-Competitive Practices
According to the complaint, Epic’s software currently holds records for more than 325 million patients, representing over 90% of U.S. citizens. Texas argues that Epic leverages this vast control to discourage healthcare providers from adopting competing EHR systems. The state alleges the company improperly denies or delays access to patient records for providers who do not utilize Epic’s platform, effectively curtailing the flow of critical medical information and potentially jeopardizing patient care.
“Epic’s pretextual denials or delays ensure that only Epic can decide which companies can compete, with which services, to which customers — thereby depriving customers of a competitive marketplace,” the state wrote in its lawsuit.
The complaint further asserts that this restriction on data flow stifles innovation by preventing other healthcare software firms and startups from accessing the information needed to develop and offer competitive services. For instance, a staffing software vendor would require access to patient data to understand service demands and care needs.
Restrictions on Parental Access and Employee Mobility
Beyond market dominance, the lawsuit also highlights concerns regarding parental access to children’s medical records. The suit points to default settings within MyChart that limit proxy access for parents when a patient reaches the age of 12. This issue is part of a broader effort by Paxton to ensure parents have unfettered access to their children’s healthcare information, following a recent settlement with a clinic accused of similar restrictions.
Adding to the allegations, the complaint details restrictive noncompete agreements imposed on Epic employees. These agreements, reportedly in place as recently as 2019, allegedly barred former employees from working at thousands of firms involved in health software, effectively limiting talent acquisition for competitors.
Epic Responds to the Lawsuit
Epic has dismissed the lawsuit as “flawed and misguided,” asserting that it fails to grasp the company’s business model and its position within the healthcare market. In a statement, Epic highlighted its extensive data exchange capabilities, claiming to handle over 725 million record exchanges each month, with more than half originating from non-Epic systems. The company also emphasized that decisions regarding parental access are ultimately made by doctors and health systems.
A History of Interoperability Concerns
Accusations of Epic hindering the free flow of health information are not new. The company has faced long-standing criticism for facilitating seamless data sharing within its own ecosystem while presenting challenges for interoperability with competing systems. In early 2020, Epic actively campaigned to modify sweeping HHS regulations aimed at promoting interoperability, seeking to ease data-sharing requirements. Those regulations were ultimately finalized.
This latest legal challenge arrives as Epic is already confronting another antitrust complaint. In September, a federal judge permitted a lawsuit filed by startup Particle Health against Epic to proceed.
The Texas lawsuit underscores the growing scrutiny of dominant players in the healthcare technology sector and the ongoing debate surrounding data access, competition, and patient rights.
